TapewireFind a company

person · Reporting owner

JOHANNESSEN JAN

Disclosed activity across 1 company

Tapewire entity
47281
SEC CIK
0001224168

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Twist Bioscience CorpTWST · Entity 3619DirectorMay 12, 2026May 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Twist Bioscience Corp

Report date May 12, 2026 · Filed May 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect17,754 Ending reported balance After 2026-05-12 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-05-12 · Exercise / conversion · Acquired 12,000 · Balance 29,754

Row 2 · 2026-05-12 · Sale · Disposed 12,000 · Balance 17,754

Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.00 · Expires 2018-10-30Direct10,304 Reported balance After 2026-05-12 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-05-12 · Exercise / conversion · Acquired 12,000 · Balance 10,304

F1: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vested and became exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vested and became exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 12, 2026 Filed May 14, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 12,000 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001214659-26-006205 · marketforms-73169.xml · derivative · entry 3

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,304

Underlying: Common Stock · 12,000 shares

Expires 2018-10-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vested and became exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 12,000 $56.12 $673,440.00
Disclosure

SEC source: 0001214659-26-006205 · marketforms-73169.xml · nonDerivative · entry 2

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,754

Read SEC document
May 12, 2026 Filed May 14, 2026 20:05 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionCommon Stock 12,000 $14.00 $168,000.00
Disclosure

SEC source: 0001214659-26-006205 · marketforms-73169.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,754

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 06, 2026 Filed Feb 9, 2026 21:26 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 2,200 $47.91 $105,394.74
Disclosure

SEC source: 0001214659-26-001339 · marketforms-72066.xml · nonDerivative · entry 2

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,754

F2 · shares: Represents the number of shares sold by the Reporting Person to cover tax liability in connection with the vesting of Restricted Stock Units. This "sell to cover" transaction was made pursuant to a prior election by the Reporting Person and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 05, 2026 Filed Feb 9, 2026 21:26 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 5,095 $0.00 $0.00
Disclosure

SEC source: 0001214659-26-001339 · marketforms-72066.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,954

F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.

Read SEC document
November 18, 2025 Filed Nov 20, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 7,044 $24.77 $174,479.88
Disclosure

SEC source: 0001214659-25-016996 · marketforms-71312.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,859

Read SEC document
February 05, 2025 Filed Feb 7, 2025 21:05 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 4,472 $0.00 $0.00
Disclosure

SEC source: 0001214659-25-002232 · marketforms-68035.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,903

F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.

Read SEC document
February 06, 2024 Filed Feb 9, 2024 21:10 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 5,815 $0.00 $0.00
Disclosure

SEC source: 0001214659-24-002249 · marketforms-64639.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,431

F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.

Read SEC document
February 09, 2023 Filed Feb 13, 2023 21:20 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 1,732 $26.46 $45,820.06
Disclosure

SEC source: 0001214659-23-002132 · marketforms-59441.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,616

F1 · kind: Represents shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
February 07, 2023 Filed Feb 9, 2023 21:15 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 8,212 $0.00 $0.00
Disclosure

SEC source: 0001214659-23-001881 · marketforms-59386.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,348

F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 21:35 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionDirector Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001214659-22-002938 · marketforms-55448.xml · derivative · entry 3

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,304

Underlying: Common Stock · 5,000 shares

Expires 2028-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 21:35 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 5,000 $59.20 $296,000.00
Disclosure

SEC source: 0001214659-22-002938 · marketforms-55448.xml · nonDerivative · entry 2

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,136

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 21:35 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionCommon Stock 5,000 $14.00 $70,000.00
Disclosure

SEC source: 0001214659-22-002938 · marketforms-55448.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 08, 2022 Filed Feb 10, 2022 22:00 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 3,491 $0.00 $0.00
Disclosure

SEC source: 0001214659-22-002207 · marketforms-55360.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,136

F1 · shares: 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.

Read SEC document
February 04, 2022 Filed Feb 8, 2022 21:35 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 253 $58.88 $14,896.39
Disclosure

SEC source: 0001214659-22-002066 · marketforms-55333.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,645

F1 · kind: Represents shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
November 17, 2021 Filed Nov 19, 2021 21:35 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionDirector Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001214659-21-012082 · marketforms-54286.xml · derivative · entry 3

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,304

Underlying: Common Stock · 5,000 shares

Expires 2028-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
November 17, 2021 Filed Nov 19, 2021 21:35 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 5,000 $115.17 $575,850.00
Disclosure

SEC source: 0001214659-21-012082 · marketforms-54286.xml · nonDerivative · entry 2

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,898

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021.

Read SEC document
November 17, 2021 Filed Nov 19, 2021 21:35 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionCommon Stock 5,000 $14.00 $70,000.00
Disclosure

SEC source: 0001214659-21-012082 · marketforms-54286.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,898

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 18, 2021 Filed Aug 20, 2021 20:33 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 5,000 $97.11 $485,550.00
Disclosure

SEC source: 0001214659-21-008866 · marketforms-53623.xml · nonDerivative · entry 2

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,898

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021.

Read SEC document
August 18, 2021 Filed Aug 20, 2021 20:33 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionCommon Stock 5,000 $14.00 $70,000.00
Disclosure

SEC source: 0001214659-21-008866 · marketforms-53623.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,898

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2021 Filed May 21, 2021 21:52 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionDirector Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001214659-21-005820 · marketforms-52852.xml · derivative · entry 3

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,304

Underlying: Common Stock · 5,000 shares

Expires 2028-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
May 19, 2021 Filed May 21, 2021 21:52 UTC Twist Bioscience Corp TWST · Entity 3619 SaleCommon Stock 5,000 $88.39 $441,950.00
Disclosure

SEC source: 0001214659-21-005820 · marketforms-52852.xml · nonDerivative · entry 2

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,898

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021.

Read SEC document
May 19, 2021 Filed May 21, 2021 21:52 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionCommon Stock 5,000 $14.00 $70,000.00
Disclosure

SEC source: 0001214659-21-005820 · marketforms-52852.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,898

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2021 Filed Aug 20, 2021 20:33 UTC Twist Bioscience Corp TWST · Entity 3619 Exercise / conversionDirector Stock Option (right to buy) · Derivative 5,000 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001214659-21-008866 · marketforms-53623.xml · derivative · entry 3

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,304

Underlying: Common Stock · 5,000 shares

Expires 2028-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
February 03, 2021 Filed Feb 6, 2021 01:30 UTC Twist Bioscience Corp TWST · Entity 3619 GrantDirector Stock Option (right to buy) · Derivative 973 $0.00 Strike: $189.96 $0.00
Disclosure

SEC source: 0001214659-21-001431 · marketforms-51433.xml · derivative · entry 2

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 973

Underlying: Common Stock · 973 shares

Expires 2031-02-02

F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
February 03, 2021 Filed Feb 6, 2021 01:30 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 486 $0.00 $0.00
Disclosure

SEC source: 0001214659-21-001431 · marketforms-51433.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,898

F1 · shares: Represents a restricted stock unit award (the "RSU Award") of which 100% vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
February 04, 2020 Filed Feb 7, 2020 02:25 UTC Twist Bioscience Corp TWST · Entity 3619 GrantDirector Stock Option (right to buy) · Derivative 5,648 $0.00 Strike: $26.20 $0.00
Disclosure

SEC source: 0001214659-20-001014 · marketforms-47687.xml · derivative · entry 2

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,648

Underlying: Common Stock · 5,648 shares

Expires 2030-02-03

F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
February 04, 2020 Filed Feb 7, 2020 02:25 UTC Twist Bioscience Corp TWST · Entity 3619 GrantCommon Stock 1,412 $0.00 $0.00
Disclosure

SEC source: 0001214659-20-001014 · marketforms-47687.xml · nonDerivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,412

F1 · shares: Represents a restricted stock unit award (the "RSU Award") of which 100% vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
February 04, 2020 Filed Mar 5, 2021 21:40 UTC Amendment Twist Bioscience Corp TWST · Entity 3619 GrantDirector Stock Option (right to buy) · Derivative 11,297 $0.00 Strike: $26.20 $0.00
Disclosure

SEC source: 0001214659-21-002797 · marketforms-51439.xml · derivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,297

Underlying: Common Stock · 11,297 shares

Expires 2030-02-03

F1 · shares: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options.

F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.

F1 · derivative.underlying_shares: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options.

F1 · balance_after: The Form 4 originally filed on February 6,2020 incorrectly reported 5,648 options.

Read SEC document
July 23, 2019 Filed Oct 9, 2019 20:33 UTC Twist Bioscience Corp TWST · Entity 3619 GrantDirector Stock Option (right to buy) · Derivative 5,590 $0.00 Strike: $30.41 $0.00
Disclosure

SEC source: 0001209191-19-052821 · doc4.xml · derivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,590

Underlying: Common Stock · 5,590 shares

Expires 2029-07-22

F1 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
July 23, 2019 Filed Mar 5, 2021 21:30 UTC Amendment Twist Bioscience Corp TWST · Entity 3619 GrantDirector Stock Option (right to buy) · Derivative 10,588 $0.00 Strike: $30.41 $0.00
Disclosure

SEC source: 0001214659-21-002782 · marketforms-51613.xml · derivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,588

Underlying: Common Stock · 10,588 shares

Expires 2029-07-22

F1 · shares: The Form 4 originally filed on October 9,2019 incorrectly reported 5,590 options.

F2 · derivative.exercise_date: 100% of the shares subject to the option will vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.

F1 · derivative.underlying_shares: The Form 4 originally filed on October 9,2019 incorrectly reported 5,590 options.

F1 · balance_after: The Form 4 originally filed on October 9,2019 incorrectly reported 5,590 options.

Read SEC document
October 30, 2018 Filed Nov 1, 2018 22:49 UTC Twist Bioscience Corp TWST · Entity 3619 GrantDirector Stock Option (right to buy) · Derivative 42,304 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001209191-18-056826 · doc4.xml · derivative · entry 1

JOHANNESSEN JAN · CIK 0001224168 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,304

Underlying: Common Stock · 42,304 shares

Expires 2028-10-29

F1 · derivative.exercise_date: 1/3rd of the shares subject to the option vest and become exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.